Summary The induction of chromosome damage by the Platinum complex CHIP in Chinese hamster ovary (CHO) cells has been studied, together with the relationship between cell survival and aberration frequency. The type and frequency of chromosome aberrations observed in asynchronous and G, phase treated cells indicated a similar mode of action to that of bifunctional alkylating agents. A log-linear relationship was observed between the frequency of chromatid aberrations (excluding gaps) and the level of survival after CHIP treatment, with approximately one aberration per cell corresponding to 37% survival.
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Cis dichloro-bis (isopropylamine) trans dihydroxy platinum IV-CHIP-is one of the new platinum co-ordination complexes in the group of potential antitumour agents, whose cytotoxic action has now been studied extensively. It can be compared with another platinum complex cis-dichloro-bis (cyclopentylamine) platinum (II), PAD, which although insoluble in water was found to have a high antitumour activity and a large therapeutic index (235), (Connors et al., 1972) . In contrast, CHIP is highly water soluble and this has encouraged further investigation into its mode of action.
Results from several workers indicate that DNA is the primary intracellular target for the cytotoxic action of the platinum complexes, where inter-and intra-strand crosslinks are produced (Roberts & Pascoe, 1972; Kelman et al., 1977) . These effects of platinum complexes on DNA point to a similar mode of action to that observed with bifunctional alkylating agents; i.e. the production of "delayed type" chromosome aberrations as a result of DNA synthesis on a damaged template (Bender et al., 1974) .
Studies were undertaken to examine this possibility and to understand better the mechanism underlying the cytotoxic action of CHIP. In this paper the results of the investigation of the production of chromosome aberrations by CHIP in Cell survival Survival of cells was determined by their colony forming ability after 5 day's growth, as described previously .
Synchrony
Synchronization was obtained by the mitotic selection method (Terasima & Tolmach, 1963) . The degree of synchrony was estimated from the measurement of the mitotic index immediately after mitotic selection. This was usually between 85-95%.
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Drug treatment
In all experiments cells were exposed to CHIP in culture medium for h at 37°C after they had adhered to the surface of the flask. The stock solution of drug was dissolved at a concentration of mg ml -in cold physiological saline and kept in the dark. All drug preparations were freshly prepared, immediately before each experiment. After the cells were exposed for 1 h the drugcontaining medium was sucked off and replaced with fresh medium. . Table I shows the frequency of aberrations in cells treated with a CHIP dose of 94 ,g ml-l after which the surviving fraction is 0.1 (Nias et al., 1979) . A relatively low frequency of aberrations was produced compared with the high cell killing observed with the same dose of CHIP. Only chromatid type aberrations were observed. After the subtraction of control levels of aberrations, a linear dose-response relationship was found ( Figure  1 ) between chromatid breaks and doses of CHIP corresponding to the exponential portion of the survival curve for clone H cells (Nias et al., 1979) .
To examine further the mechanism of production of aberrations by CHIP, the frequency of aberrations in the cells treated in G1 and G2 phase with 94 Mg ml-1 of the drug, was investigated. The effect of CHIP on the cells treated in G1 phase was determined using synchronous cell populations. Mitotic cells were plated (-1-3 x 105 cells per flask) and after 1.5 h treated with CHIP. Colcemid was added to the cultures for the last 3 h of the experiment (i.e. between 10th and 13th h of experiment). Mitotic cells were subsequently shaken off at the first mitosis after treatment.
Asynchonous populations of cells were used to determine the effects of CHIP on cells in G2 phase. Cells were treated with the drug for 1 h and with colcemid for a further hour. Thereafter, mitotic Figure 1 ) because of the lower sensitivity of these cells.
Correlation between chromosome aberrations and cell killing Figure 2 shows the survival curve for CHO clone 10 cells exposed to CHIP. The parameters of this curve are: D= 19pgml l, Dq=27pgml-', n=4.1.
The survival of these cells, as a function of lethal aberrations (i.e. all aberrations per cell excluding gaps) found at the 1st mitosis after treatment with CHIP, is presented in Figure 3 . There is a log-linear relationship between aberration frequency and cell survival, with 0.85 aberrations per cell corresponding to 37% survival.
Discussion
Mechanism of aberration production Data given in Table I show that CHIP induces all types of chromatid aberrations at the first mitosis after treatment but only in cells exposed to the drug in G, and S phases. acts in a similar way to the bifunctional alkylating agents and to UV light and, therefore, falls into Class III of Bender's Classification of chemicals. These are the group of agents producing chromatid aberrations from drug-induced single strand lesions delivered in G1-S phase which are expressed during S phase as a result of DNA synthesis on the damaged template and are revealed at the first mitosis thereafter. They are therefore described as "delayed-type" aberrations (Bender et al., 1974) . A higher incidence of gaps in cells treated with CHIP in G2 phase, as compared to the control, was obtained and this is in agreement with the findings of Bender et al. (1973) and Hittelman & Rao (1974) who also found that UV light and alkylating agents produced gaps in G2 treated cells. The nature of the production of gaps is still not clear, but Bender et al. (1974) suggested in their general model of aberration production, that a single polynucleotide strand break could be manifested at metaphase, as an achromatic lesion or gap. If this model is correct, gaps produced by CHIP in G2 phase cells could be a result of the operation of excision-type repair processes. Because of the uncertainty about their contribution to lethality the gap data were excluded from Figure 3 .
Other platinum complexes such as cis-diammine dichloro platinum (II) (cis-PDD) and cisdichlorobis (cyclopentylamine) platinum (II) (PAD) have also been found to produce chromatid aberrations of the "delayed type" (Van den Berg & Roberts, 1975; Meyene & Lockhart, 1978) . However, Szumiel and Nias (1976) showed in the same system of CHO cells that at the first mitosis after treatment of cells in G1 phase with PAD no exchanges or isochromatid breaks were produced. These were only seen at the second mitosis. The model presenting the mechanism of action of PAD on chromosomes was given by Chadwick et al. (1976) . It implies that only single polynucleotide strand breaks opposite damaged regions are produced during the first DNA replication after treatment of cells with PAD. This means that cells are unable to excise lesions in DNA produced by PAD. According to Bender's general theory of chromatid aberration production, chromatid breaks and exchanges arise as a consequence of the second DNA replication. Thus, in cells treated with PAD, mainly gaps were seen at the first mitosis after treatment, and breaks and exchanges at the second mitosis after treatment whilst CHIP produced all types of chromatid aberrations, including isochromatid breaks and exchanges, at the first mitosis after treatment.
There is evidence for the ability of cells to repair platinum-induced lesions in DNA (Roberts et al., 1982) . Therefore, the reason for the differences observed in aberration production by CHIP and PAD could partly lie in the differing ability of the cells to excise the lesions induced by the two platinum complexes which itself might also be connected with the different type and/or position of the lesions produced.
Endoreduplicated cells were observed after treatment with CHIP. It is well known that as a consequence of the endoreduplication process, daughter cells frequently receive differing chromosome complements as a result of nondisjunction and multipolar divisions and this also leads to the polyploidisation of cells. It has been found that endoreduplication can also be induced in the second and subsequent generations after treatment of cells with other chemicals such as # mercapto-ethanol and nitroquinoline-I oxide and also with x-irradiation (Suton, 1973) . 7he frequency of chromosome aberrations and cell killing Although there is a well-established relationship between chromosomal aberrations and radiationinduced cell death (e.g. Dewey et al., 1978) , the contribution of chromosomal aberrations to cell lethality induced by chemical agents has been studied to a much lesser extent (reviewed by Scott, 1977) . Platinum compounds were not included in these studies nor in the quantitative comparison of cytogenetic effects of x-rays and anti-tumour drugs by Parkes & Scott (1982) . It therefore seemed of interest to analyze the relationship between the clonogenic ability of CHIP treated cells and the frequency of chromosomal aberrations.
These parameters have been determined on different cell populations; asynchronous for survival determination by cloning and synchronous (G1) for analysis of chromatid aberrations. This was justifiable because of the lack of sensitivity dependence on cell age (Ackers, 1983) . Such a lack of dependence was found earlier with PAD for which also observed no age dependency of cytotoxic activity.
The data on chromatid aberration frequency were taken from Table II . CHIP induced mitotic delay is dose dependent and this was confirmed by pulse labelling the synchronous CHO cell population treated with a dose of CHIP to give a SF of 0.1 as well as from clone-size analysis for the dose of CHIP giving survival levels of 0.4 and 0.1 respectively (Ackers, 1983) . It was therefore plausible to assume that the more sensitive clone 10 cells treated with the highest (90.9 Mg ml-1) dose of CHIP (SF = 0.03) did not pass their first mitosis after treatment at the time interval studied. These data on aberration frequency have been plotted with the corresponding survival data in Figure 3 .
As can be seen, survival of CHO cells exposed to CHIP is log-linearly related to the chromatid aberration frequency with a level of 0.85 aberrations per cell corresponding to 37% survival. It was also found that the doses of CHIP reducing survival of both CHO clone H and clone 10 to a similar level induce similar frequencies of chromatid aberrations (Tables I and II A positive correlation between the lethal effects of PAD and the frequency of chromatid breaks in two mouse lymphoma L5178Y cell strains, differing in their sensitivity to PAD, was found by Szumiel (1979) . A similar correlation between sensitivity to sulphur mustard and x-irradiation with chromosome aberration frequency in two Yoshida strains was also observed by Scott et al. (1974) . On the other hand, Parkes & Scott (1982) found no correlation between the incidence of structural aberrations and the survival of diploid human fibroblasts when the effects of x-rays and four other cytotoxic agents were compared at equitoxic doses.
A log-linear relationship similar to that shown in Figure 3 between survival and chromatid aberration frequency was shown in x-irradiated CHO cells by Dewey et al. (1978) . Their results suggested that only one aberration per cell is required for cell death and that chromatid type aberrations appeared to be as lethal as the chromosome type. So far, there are no satisfactory explanations of these observations.
Aberrations which affect only one sister chromatid would be expected to result in 50% cytologically normal daughter cells after the first mitosis. This would only be correct for cells which have one aberration per cell and therefore it would relate only to those cells treated with the lowest dose of drug used in this study. The good correlation between survival and chromatid aberration frequency may result from a delayed formation of chromosomal aberrations in cells originating from the apparently normal first generation cells. It may also be fortuitous that other lethal events, not discernible cytologically, log-linearly related to the drug dose, may increase the lethality in a manner apparently related to the aberration frequency. One such event may be that leading to interphase cell death.
Conclusion
Our experiments here have confirmed that CHIP can be classified, along with other platinum coordination complexes and bifunctional alkylating agents, into Class III of Bender's chemical classification (Bender et al., 1974) . Differences observed in the type of chromatid aberrations produced by PAD and CHIP, especially at first mitosis after treatment, suggested differences of type and position of the lesions induced by the two compounds in DNA. This in turn could affect the cells' ability to excise the lesions. We have also found a log-linear relationship between survival and the chromatid aberration frequency determined at first mitosis after treatment.
